MedTrace Logo

PENG With LFCB vs. ESP Blocks for Pediatric Hip Surgery

NCT07023094 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2025-07-11

No results posted yet for this study

Summary

This randomized controlled trial (RCT) compares the analgesic effectiveness of two regional anesthesia techniques-Pericapsular Nerve Group (PENG) block combined with Lateral Femoral Cutaneous Nerve Block (LFCB) versus Lumbar and Sacral Erector Spinae Plane Blocks (L-ESPB and S-ESPB)-in pediatric patients undergoing hip surgery.

Conditions

  • Hip Disease
  • Hip Dysplasia
  • Hip Arthropathy

Interventions

DRUG

Ropivacaine 0.2% for PENG Block

U-S guided PENG (0.4 mL/kg) with 0.2% ropivacaine

DRUG

Ropivacaine 0.2% for LFCB

LFCB (0.1 mL/kg) with 0.2% ropivacaine

DRUG

Ropivacaine 0.2% for L-ESPB

Lumbar ESPB (0.25ml/kg) with 0.2% ropivacaine

DRUG

Ropivacaine 0.2% for S-ESPB

Sacral ESPB (0.25ml/kg) with 0.2% ropivacaine

Sponsors & Collaborators

  • Poznan University of Medical Sciences

    lead OTHER

Principal Investigators

  • Malgorzata Reysner, M.D. Ph.D. · Poznan University of Medical Sciences

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
2 Years
Max Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-16
Primary Completion
2026-05-30
Completion
2026-06-30

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07023094 on ClinicalTrials.gov